Scientists have identified a new regulator of the innate immune response--the immediate, natural immune response to foreign invaders. The study suggests that therapeutics that modulate the regulator--an immune checkpoint--may represent the next generation of antiviral drugs, vaccine adjuvants, cancer immunotherapies, and treatments for autoimmune disease.